194 related articles for article (PubMed ID: 28620381)
1. FXYD5 Is an Essential Mediator of the Inflammatory Response during Lung Injury.
Brazee PL; Soni PN; Tokhtaeva E; Magnani N; Yemelyanov A; Perlman HR; Ridge KM; Sznajder JI; Vagin O; Dada LA
Front Immunol; 2017; 8():623. PubMed ID: 28620381
[TBL] [Abstract][Full Text] [Related]
2. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.
Maus UA; Wellmann S; Hampl C; Kuziel WA; Srivastava M; Mack M; Everhart MB; Blackwell TS; Christman JW; Schlöndorff D; Bohle RM; Seeger W; Lohmeyer J
Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L350-8. PubMed ID: 15516494
[TBL] [Abstract][Full Text] [Related]
3. FXYD5 Protein Has a Pro-inflammatory Role in Epithelial Cells.
Lubarski-Gotliv I; Asher C; Dada LA; Garty H
J Biol Chem; 2016 May; 291(21):11072-82. PubMed ID: 27006401
[TBL] [Abstract][Full Text] [Related]
4. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
Jing W; Chunhua M; Shumin W
Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
[TBL] [Abstract][Full Text] [Related]
5. Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury.
Lee JW; Park JW; Shin NR; Park SY; Kwon OK; Park HA; Lim Y; Ryu HW; Yuk HJ; Kim JH; Oh SR; Ahn KS
Int J Mol Med; 2016 Sep; 38(3):834-44. PubMed ID: 27431288
[TBL] [Abstract][Full Text] [Related]
6. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
7. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
Luo Y; Che W; Zhao M
Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
[TBL] [Abstract][Full Text] [Related]
8. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
Feng G; Sun B; Li TZ
Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
[TBL] [Abstract][Full Text] [Related]
9. Febrile-range hyperthermia augments lipopolysaccharide-induced lung injury by a mechanism of enhanced alveolar epithelial apoptosis.
Lipke AB; Matute-Bello G; Herrero R; Kurahashi K; Wong VA; Mongovin SM; Martin TR
J Immunol; 2010 Apr; 184(7):3801-13. PubMed ID: 20200273
[TBL] [Abstract][Full Text] [Related]
10. Alveolar NF-κB signaling regulates endotoxin-induced lung inflammation.
Lopez B; Maisonet TM; Londhe VA
Exp Lung Res; 2015 Mar; 41(2):103-14. PubMed ID: 25517107
[TBL] [Abstract][Full Text] [Related]
11. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide.
Kang JL; Lee HW; Lee HS; Pack IS; Chong Y; Castranova V; Koh Y
Am J Respir Crit Care Med; 2001 Dec; 164(12):2206-12. PubMed ID: 11751189
[TBL] [Abstract][Full Text] [Related]
12. Silencing Angiopoietin-Like Protein 4 (ANGPTL4) Protects Against Lipopolysaccharide-Induced Acute Lung Injury Via Regulating SIRT1 /NF-kB Pathway.
Guo L; Li S; Zhao Y; Qian P; Ji F; Qian L; Wu X; Qian G
J Cell Physiol; 2015 Oct; 230(10):2390-402. PubMed ID: 25727991
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice.
Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573
[TBL] [Abstract][Full Text] [Related]
14. Water extract of Helminthostachys zeylanica attenuates LPS-induced acute lung injury in mice by modulating NF-κB and MAPK pathways.
Liou CJ; Huang YL; Huang WC; Yeh KW; Huang TY; Lin CF
J Ethnopharmacol; 2017 Mar; 199():30-38. PubMed ID: 28119099
[TBL] [Abstract][Full Text] [Related]
15. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
16. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
[TBL] [Abstract][Full Text] [Related]
17. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages.
Kim HJ; Lee HS; Chong YH; Kang JL
Toxicology; 2006 Aug; 225(1):36-47. PubMed ID: 16793190
[TBL] [Abstract][Full Text] [Related]
18. c-Jun Is Required for Nuclear Factor-κB-Dependent, LPS-Stimulated Fos-Related Antigen-1 Transcription in Alveolar Macrophages.
Mishra RK; Potteti HR; Tamatam CR; Elangovan I; Reddy SP
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):667-674. PubMed ID: 27286066
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody against Toll-like receptor 4 attenuates ventilator-induced lung injury in rats by inhibiting MyD88- and NF-κB-dependent signaling.
Huang C; Pan L; Lin F; Dai H; Fu R
Int J Mol Med; 2017 Mar; 39(3):693-700. PubMed ID: 28204830
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
